Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Individual and ethnic differences in CYP2C19 activity in Chinese populations.

× No keyword cloud information.

11 in total

1. Effect of CYP2C19 genotypes on the pharmacokinetic/pharmacodynamic relationship of rabeprazole after a single oral dose in healthy Chinese volunteers.

Authors: Yu-Cheng Sheng; Kun Wang; Ying-Chun He; Juan Yang; Qing-Shan Zheng
Journal: Eur J Clin Pharmacol Date: 2010-09-14 Impact factor: 2.953

2. The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.

Authors: Guo Wang; He-Ping Lei; Zhi Li; Zhi-Rong Tan; Dong Guo; Lan Fan; Yao Chen; Dong-Li Hu; Dan Wang; Hong-Hao Zhou
Journal: Eur J Clin Pharmacol Date: 2008-11-04 Impact factor: 2.953

3. Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C191 and CYP2C192 on the pharmacokinetic profile of lansoprazole.

Authors: Imad Zalloum; Nancy Hakooz; Tawfiq Arafat
Journal: Mol Biol Rep Date: 2011-07-17 Impact factor: 2.316

4. Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype.

Authors: Hai-Ling Qiao; Yu-Rong Hu; Xin Tian; Lin-Jing Jia; Na Gao; Li-Rong Zhang; Yu-Zhong Guo
Journal: Eur J Clin Pharmacol Date: 2006-01-10 Impact factor: 2.953

5. Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.

Authors: Xing-Mei Han; Dong-Sheng Ouyang; Xiao-Ping Chen; Yan Shu; Chang-Hong Jiang; Zhi-Rong Tan; Hong-Hao Zhou
Journal: Br J Clin Pharmacol Date: 2002-11 Impact factor: 4.335

6. Non-Carriers of Reduced-Function CYP2C19 Alleles are Most Susceptible to Impairment of the Anti-Platelet Effect of Clopidogrel by Proton-Pump Inhibitors: A Pilot Study.

Authors: Jen-Kuang Lee; Cho-Kai Wu; Jyh-Ming Juang; Chia-Ti Tsai; Juey-Jen Hwang; Jiuun-Lee Lin; Fu-Tien Chiang
Journal: Acta Cardiol Sin Date: 2016-03 Impact factor: 2.672

7. Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population.

Authors: Wei-Xing Shi; Shu-Qing Chen
Journal: World J Gastroenterol Date: 2004-07-01 Impact factor: 5.742

8. Prevalence of CYP2C19 gene polymorphisms in the Puerto Rican population: a preliminary report.

Authors: Jorge Duconge; Carmen L Cadilla; Jessica Y Renta; Pamela Silén-Rivera; Paola Piovanetti; Rafael García-Berdecía; Liza M Castro-Rosario; Shalom Monzón; Linet Vélez; Guillermo Rosas; Jhon A Guerra; Pedro J Santiago-Borrero
Journal: P R Health Sci J Date: 2008-12 Impact factor: 0.705

9. Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk: evidence from 11,042 subjects.

Authors: Bo Zhou; Zhenshun Song; Mingping Qian; Liang Li; Jian Gong; Shaowu Zou
Journal: PLoS One Date: 2013-07-16 Impact factor: 3.240

10. The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro.

Authors: Ren-Ai Xu; Er-Min Gu; Teng-Hui Liu; Qiu-Geng Ou-Yang; Guo-Xin Hu; Jian-Ping Cai
Journal: Infect Drug Resist Date: 2018-11-01 Impact factor: 4.003